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Details regarding analyses of permissive vs. enhancing sequence parameters.   We evaluated whether some sequence parameters have a differential influence across the range of observed expression and solubility score values.  A parameter can potentially show an equivalent effect across the entire score range; in this case, an increase in the parameter would have the same influence on the probability of scoring 0 vs. 1 for expression as for scoring 3 vs. 4 for expression.  Alternately, factors could operate differently at different ends of the score spectrum.  For instance, some sequence parameters, which we dub “permissive”, could have a large influence on whether a protein scores 0 vs. any higher value but less influence on the distribution of scores above 0.  Alternatively, other sequence parameters, which we dub “enhancing”, could have a large influence on whether a protein scores 5 vs. any lower value but less influence on the distribution of scores below 5.  Framing this issue mathematically involves evaluating whether the slopes of the paired binary logistic regressions between adjacent ordinal score values change significantly over the observed score range.  Therefore, for every significant sequence parameter, we calculated the Brant statistic [83], which evaluates the likelihood that the slopes between different outcome steps in an ordinal logistic regression are equal, and we also ran simple binary logistic regressions based our definitions of permissive (0 vs. 1-5) and enhancing (0-4 vs. 5).  Fig. S4 shows signed ‑log(p) values for these regressions for all factors which were significant predictors of expression or solubility score, sorted by the significance of their Brant statistic.

The majority of expression-predicting parameters differed significantly in their influence across the range of E values.  Permissive sequence parameters include the fractional number of charges, SCE, fractional exposed Lys content, exposed SCE, and fractional Glu content.  Parameters opposing permissiveness include GRAVY and fractional Pro, Leu, Gly, and Ala content.  Enhancing sequence parameters include the fractional Asp, buried Met, and His content.  Parameters opposing enhancement include net charge, fractional predicted backbone disorder, fractional exposed Arg content, and fractional absolute net charge.  Gln showed no significant difference in its influence on expression throughout the range of E scores, and a few parameters (GRAVY, net charge, and fractional Glu, exposed Arg, Asp, and Ala content) showed significant effects that differed substantially in magnitude over the score range.  No parameter had an opposite influence on permissiveness vs. enhancement.

For solubility score, fractional predicted backbone disorder and fractional exposed Gln content are permissive but not enhancing.  All other sequence parameters had significant effects on both permissiveness and enhancement.  SCE, exposed SCE, fractional exposed Lys content, and fraction of charged residues were primarily permissive, while GRAVY, chain length, and fractional buried Gly, buried Phe, buried Thr, Cys, and Ile content primarily opposed permissiveness.  Fractional exposed Asp content was primarily enhancing, while net charge and fractional Arg content primarily opposed enhancement.  All other significant predictors had a similar influence on permissiveness vs. enhancement.







Supplemental Materials and Methods.

Crystallization.   Initial high-throughput crystallization screening was conducted using the 1536 well microbatch robotic screen at the Hauptmann-Woodward Institute [35, 86].  Proteins failing to yield rapidly progressing crystal leads were subjected to vapor diffusion screening, typically 250-300 conditions (Crystal Screens I & II, PEG-Ion, and Index screens from Hampton Research or equivalent screens from Qiagen) at both 4˚ C and 20˚ C.  These latter screens were conducted in the presence of substrate or product compounds if commercially available.  Crystal optimization, diffraction data collection at cryogenic temperatures, structure solution using single or multiple-wavelength anomalous diffraction techniques, and refinement were conducted using standard methods [35, 85].





































































a Results from single logistic regressions of fractional amino acid content against expression level (E), solubility score (S), and usability (E*S > 11).  Slope and p-value are shown.  Parameters with p-values below the Bonferroni-corrected threshold of 0.0007 are shown in bold.  The nomenclature describing amino acid content is described in Table 1 in the main text.
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a Results of single logistic regressions against expression level (E) and solubility score (S) for compound sequence parameters.  Slope, standard error, Z score, and p-value are shown.  P-values below the Bonferroni-corrected threshold of 0.0007 are shown in bold.  The nomenclature describing the compound sequence parameters is described in Table 1 in the main text.


Table S3.  Parameter coefficients in final predictive models. a 




















































































































Figure S14: Expression and solubility score distributions for potential signal-peptide-containing and transmembrane proteins.   This bubble plot shows the E and S score distributions for the 865 proteins in the Analysis Dataset that have above-threshold predictions of having a signal peptide, lipopeptide, or transmembrane helix.  (See Methods section in the main text for more information.)  The presentation format is equivalent to that in Fig. 1C in the main text.  The area of each point is proportional to the number of proteins with the indicated combination of expression and solubility scores.




